This post was written by guest author Scarlett Dargan. Scarlett read History at Churchill College, Cambridge. She is now studying for a master’s in journalism at… Read More »‘The tragedy of thousands who need not die’: A history of cervical screening in England Part I
In this post Georgia Mannion-Krase (@GeorgiaMKrase) updates us on events at the E-Cigarette (EC) Summit held at the Royal Society on the 14th November 2019.… Read More »Smoking: it’s the end of the word as we know it. Report from the e-Cigarette summit.
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and… Read More »Five minutes with: Professor Kirsten McCaffery
Deep down every epidemiologist imagines themselves as Sherlock Holmes: equipped with little more than a magnifying glass and a good brain, they dream of becoming… Read More »The Mysterious Case of an American Epidemic of Vaping-Related Lung Injuries
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and… Read More »Five Minutes With: Professor Richard Sullivan
Clinical predictions are based on past experiences of a given population. In this post David Armstrong, Professor of Medicine and Sociology at King’s College London… Read More »The idea of a population
In this post, Peter Sasieni argues that it is time to be more specific about our definitions of specificity and false positive tests. How will… Read More »Screening iconoclasm series: Could you be more specific about what you mean by specificity?
Trying to say what would have happened is difficult. Alternate history is a type of fiction that explores what might have happened if a particular… Read More »Cervical Cancer: The Epidemic that never was!
By Professor Liam Bourke, Sheffield Hallam University There are lots of reasons for this. The subject matter is complex. Capturing and recording prospective data in… Read More »Generating good evidence for new cancer treatments is seriously tough.
I’m sure there will be many obituaries over the coming days, and if you want a synopsis of Professor Altman’s accomplishments you can read his… Read More »Doug Altman – A Giant Among Statisticians
